Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a novel antisense transcript mapped to the TRA2A locus (transformer 2 alpha homolog). Antisense transcripts are RNA molecules transcribed in the direction opposite to a sense gene and may participate in regulatory mechanisms affecting the expression of their sense counterparts, but most antisense transcripts remain poorly characterized. No protein product or drug-target function is associated with ENSG00000294729, and its biological significance is uncertain. The established drug target in this locus is TRA2A itself, a sequence-specific RNA-binding protein involved in pre-mRNA splicing[1][3][5]. If the intent is biomedical target selection, TRA2A (transformer 2 alpha homolog) is the correct canonical name and drug target, not the antisense transcript. The transcript referenced does not meet conventional criteria for drug targeting or therapeutic relevance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to transformer 2 alpha homolog (None).